Browse the corpus
Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.
1 passage
REFERENCES Carrey NJ, Wiggins DM, and Milin RP, “Pharmacological Treatment of Psychiatric Disorders in Children and Adolescents,” Drugs , 1996, 51(5):750-9. [PubMed 8861545 ] Gammans RE, Mayol RF, and LaBudde JA, "Metabolism and Disposition of Buspirone," Am J Med , 1986, 80(3B):41-51. [PubMed 3515929 ] Hanna GL, Feibusch EL, and Albright KJ, “Buspirone Treatment of Anxiety, Associated With Pharyngeal Dysphagia in a Four-Year Old,” J Child Adolesc Psychopharmacol , 1997, 7(2):137-43. [PubMed 9334898 ] Kutcher SP, Reiter S, Gardner DM, et al, “The Pharmacotherapy of Anxiety Disorders in Children and Adolescents,” Psychiatr Clin North Am , 1992, 15(1):41-67. [PubMed 1549548 ] Pfeffer CR, Jiang H, and Domeshek LJ, “Buspirone Treatment of Psychiatrically Hospitalized Prepubertal Children With Symptoms of Anxiety and Moderately Severe Aggression,” J Child Adolesc Psychopharmacol , 1997, 7(3):145-55. [PubMed 9466232 ] Simeon JG, Knott VJ, DuBois C, et al, “Buspirone Therapy of Mixed Anxiety Disorders in Childhood and Adolescence: A Pilot Study,” J Child Adolesc Psychopharmacol , 1994, 4(3):159-70. Soni P and Weintraub AL, “Buspirone-Associated Mental Status Changes,” J Am Acad Child Adolesc Psychiatry , 1992, 31(6):1098-9. [PubMed 1429411 ] Topic 13102 Version 42.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [0504-118.195.65.247-05EE575892-S244013.14]